白蛋白可抑制血小板活化因子（PAF）诱导的血小板和巨噬细胞反应：对PAF生物活性形式的影响。
Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.
作者信息
Grigoriadis G, Stewart A G
机构信息
Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.
出版信息
Br J Pharmacol. 1992 Sep;107(1):73-7. doi: 10.1111/j.1476-5381.1992.tb14465.x.
Abstract
- Platelet-activating factor (PAF) binds with high affinity to albumin leading Clay et al. (1990) to suggest that the active form of PAF is the albumin-PAF complex. 2. In the present study the proposal that albumin-bound, rather than monomeric PAF, is the active form of PAF at PAF receptors was critically evaluated by examining the effect of albumin on the potency of PAF in isolated platelets and macrophages. 3. Bovine serum albumin inhibited concentration-dependently PAF-induced responses in platelets and macrophages. The most probable explanation of this finding is that BSA reduced the concentration of free PAF. 4. Thus, we conclude that free PAF, rather than the albumin-PAF complex is the active form. Consequently, local concentrations of albumin will influence profoundly the potency of endogenously released PAF. Moreover, estimates of the affinity of PAF for PAF receptors made in buffers containing BSA, underestimate the true affinity of PAF for its receptors by approximately 3 orders of magnitude.
摘要
- 血小板活化因子（PAF）与白蛋白具有高亲和力结合，这使得克莱等人（1990年）提出PAF的活性形式是白蛋白-PAF复合物。2. 在本研究中，通过检查白蛋白对分离的血小板和巨噬细胞中PAF效力的影响，对PAF受体处与白蛋白结合而非单体PAF是PAF活性形式这一观点进行了严格评估。3. 牛血清白蛋白浓度依赖性地抑制血小板和巨噬细胞中PAF诱导的反应。这一发现最可能的解释是牛血清白蛋白降低了游离PAF的浓度。4. 因此，我们得出结论，游离PAF而非白蛋白-PAF复合物是活性形式。因此，白蛋白的局部浓度将深刻影响内源性释放的PAF的效力。此外，在含有牛血清白蛋白的缓冲液中对PAF与PAF受体亲和力的估计，将PAF对其受体的真实亲和力低估了约3个数量级。
相似文献
1
Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.白蛋白可抑制血小板活化因子（PAF）诱导的血小板和巨噬细胞反应：对PAF生物活性形式的影响。
Br J Pharmacol. 1992 Sep;107(1):73-7. doi: 10.1111/j.1476-5381.1992.tb14465.x.
2
1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.1-O-十六烷基-2-乙酰基-sn-甘油-3-磷酸（N，N，N-三甲基）己醇胺：一种具有部分激动剂活性的血小板活化因子类似物。
Br J Pharmacol. 1991 Sep;104(1):171-7. doi: 10.1111/j.1476-5381.1991.tb12403.x.
3
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists.醚键连接的磷脂诱导的血小板聚集。2. 血小板活化因子对兔血小板脱敏的机制及其拮抗剂抑制作用的可逆性。
Thromb Res. 1987 Apr 1;46(1):153-61. doi: 10.1016/0049-3848(87)90215-5.
4
5
Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.锌离子对[3H]血小板活化因子（PAF）结合的抑制作用：对其在人血小板中特异性PAF抗聚集作用的一种可能解释。
Arch Biochem Biophys. 1989 Aug 1;272(2):466-75. doi: 10.1016/0003-9861(89)90241-5.
6
Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.前西班牙酮，一种来自益母草的新型血小板活化因子受体拮抗剂。
Br J Pharmacol. 1991 Jul;103(3):1719-24. doi: 10.1111/j.1476-5381.1991.tb09853.x.
7
Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells.在洗涤过的人血小板和单核细胞/巨噬细胞样U937细胞中发现了脂蛋白相关血小板激活因子（LA-paf）。
Chem Phys Lipids. 1994 Apr 19;70(2):109-19. doi: 10.1016/0009-3084(94)90079-5.
8
CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.CV 6209是豚鼠腹腔常驻巨噬细胞上血小板活化因子受体的非竞争性拮抗剂。
Clin Exp Pharmacol Physiol. 1989 Nov;16(11):813-20. doi: 10.1111/j.1440-1681.1989.tb01520.x.
9
Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.一种新型噻吩二氮卓衍生物作为血小板活化因子拮抗剂的药理活性
Arzneimittelforschung. 1990 Nov;40(11):1201-5.
10
Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit platelets.外源性二酰甘油与人类血小板中的血小板活化因子（PAF）协同作用，但抑制PAF诱导的兔血小板反应。
J Lipid Mediat Cell Signal. 1996 Dec;15(1):69-87. doi: 10.1016/s0929-7855(96)00549-4.
引用本文的文献
1
Incremental Prognostic Value of Admission Blood Glucose to Albumin Ratio in Patients with Acute Coronary Syndrome: A Retrospective Observational Cohort Study.急性冠脉综合征患者入院血糖与白蛋白比值的增量预后价值：一项回顾性观察队列研究
Rev Cardiovasc Med. 2025 Apr 24;26(4):26567. doi: 10.31083/RCM26567. eCollection 2025 Apr.
2
Higher Neutrophil-Percentage-to-Albumin Ratio Was Associated with Poor Outcome in Endovascular Thrombectomy Patients.较高的中性粒细胞与白蛋白比值与血管内血栓切除术患者的不良预后相关。
Ther Clin Risk Manag. 2025 Apr 26;21:565-573. doi: 10.2147/TCRM.S519263. eCollection 2025.
3
Safety of human serum albumin infusion in heart failure patients with hypoproteinemia: a propensity score-matched analysis.低蛋白血症心力衰竭患者输注人血白蛋白的安全性：倾向评分匹配分析
Clinics (Sao Paulo). 2025 Apr 24;80:100659. doi: 10.1016/j.clinsp.2025.100659. eCollection 2025.
4
Indocyanine Green-Labeled Platelets for Survival and Recovery Studies.用于存活和恢复研究的吲哚菁绿标记血小板。
Transfus Med Hemother. 2023 Oct 16;51(2):66-75. doi: 10.1159/000533623. eCollection 2024 Apr.
5
Association between alkaline phosphatase to albumin ratio and mortality among patients with sepsis.碱性磷酸酶与白蛋白比值与脓毒症患者死亡率的关系。
Sci Rep. 2024 Feb 7;14(1):3170. doi: 10.1038/s41598-024-53384-7.
6
A nomogram for predicting the risk of venous thromboembolism in patients with solid cancers.实体瘤患者静脉血栓栓塞风险预测列线图
J Thromb Thrombolysis. 2023 Oct;56(3):414-422. doi: 10.1007/s11239-023-02856-0. Epub 2023 Jul 18.
7
Assessment of fibrinogen albumin ratio in patients with pregnancy-related cerebral venous thrombosis.评估妊娠相关性脑静脉血栓形成患者的纤维蛋白原-白蛋白比值。
Acta Neurol Belg. 2023 Dec;123(6):2251-2258. doi: 10.1007/s13760-023-02294-y. Epub 2023 May 22.
8
Malnutrition and Risk of Mortality in Ischemic Stroke Patients Treated With Intravenous Thrombolysis.接受静脉溶栓治疗的缺血性中风患者的营养不良与死亡风险
Front Aging Neurosci. 2022 Feb 21;14:834973. doi: 10.3389/fnagi.2022.834973. eCollection 2022.
9
Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study.低血清白蛋白预示新冠病毒感染的严重结局：一项单中心回顾性病例对照研究
J Clin Med Res. 2021 May;13(5):258-267. doi: 10.14740/jocmr4507. Epub 2021 May 25.
10
Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy.接受血管内血栓切除术治疗的缺血性中风患者的血清白蛋白水平与临床结局
Neuropsychiatr Dis Treat. 2021 Feb 10;17:401-411. doi: 10.2147/NDT.S293771. eCollection 2021.
本文引用的文献
1
Metabolism of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by cell cultures.细胞培养物对1-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱的代谢
Life Sci. 1982 Dec 20;31(25):2891-8. doi: 10.1016/0024-3205(82)90680-4.
2
Characteristics of the binding of platelet-activating factor to platelets of different animal species.血小板活化因子与不同动物物种血小板结合的特性。
Eur J Pharmacol. 1984 Oct 15;105(3-4):309-15. doi: 10.1016/0014-2999(84)90623-x.
3
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.兔血小板中白细胞依赖性组胺释放。IgE、嗜碱性粒细胞和血小板激活因子的作用。
J Exp Med. 1972 Dec 1;136(6):1356-77. doi: 10.1084/jem.136.6.1356.
4
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin.血小板活化因子（PAF）从人多形核白细胞（PMN）的合成与释放的调节：细胞外白蛋白的作用
Arch Biochem Biophys. 1985 Sep;241(2):337-47. doi: 10.1016/0003-9861(85)90555-7.
5
The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor.牛血清白蛋白对前列腺素合成及[3H]乙酸掺入血小板活化因子的影响。
Arch Biochem Biophys. 1987 Sep;257(2):251-8. doi: 10.1016/0003-9861(87)90564-9.
6
Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.醚键连接的磷脂诱导的血小板聚集。1. 牛血清白蛋白和血小板活化因子结构类似物的抑制作用。
Thromb Res. 1987 Apr 1;46(1):51-63. doi: 10.1016/0049-3848(87)90206-4.
7
Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol.巨噬细胞胞质溶胶中蛋白质催化血小板活化因子转移的证据。
Biochim Biophys Acta. 1988 Jul 1;961(1):48-52. doi: 10.1016/0005-2760(88)90129-4.
8
Perspectives in platelet-activating factor research.血小板活化因子研究的展望
Pharmacol Rev. 1987 Jun;39(2):97-145.
9
Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.血小板、多形核白细胞和巨噬细胞上血小板活化因子受体的特性研究。
Br J Pharmacol. 1988 Aug;94(4):1225-33. doi: 10.1111/j.1476-5381.1988.tb11642.x.
10
Binding of platelet activating factor to albumin.血小板活化因子与白蛋白的结合。
Biochim Biophys Acta. 1990 Oct 1;1046(3):309-14. doi: 10.1016/0005-2760(90)90246-t.
Zotero 插件